SECsense Logo

IGM Biosciences 8-K Report: Key Insights and Updates - January 2025

$IGMS
Form 8-K
Filed on: 2025-01-10
Source
IGM Biosciences 8-K Report: Key Insights and Updates - January 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: IGM Biosciences, Inc.
  • CIK (Central Index Key): 0001496323
  • Address: 325 E. Middlefield Road, Mountain View, CA 94043
  • Phone: (650) 965-7873
  1. Document Type:
  • Filing Type: 8-K (Current Report)
  • Filing Date: January 7, 2025.
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.01 per share
  • Ticker Symbol: IGMS
  • Exchange: NASDAQ
  1. Reporting Period:
  • Date of Report: January 7, 2025
  • Context ID: duration_2025-01-07_to_2025-01-07
  1. Regulatory Information:
  • SEC File Number: 001-39045
  • Employer Identification Number (EIN): 77-0349194

Insights:

  • The report is a Form 8-K, which typically indicates that the company is disclosing significant events that may be of interest to shareholders and the SEC.
  • The filing date coincides with the reporting date, suggesting that it may include timely or urgent information.
  • The company operates in the biotechnology sector, as inferred from the name, which could indicate a focus on healthcare innovation and potential volatility in stock pricing based on clinical trials, regulatory approvals, or market changes.
  • The presence of a common stock offering signifies that the company may be actively engaging with investors or making announcements regarding financial performance or corporate actions.

This summary captures the essential elements of the filing and contextualizes them within the regulatory and financial framework relevant to investors and analysts.